SPA Microgen

Microgen (NPO Microgen) is a leading Russian pharmaceutical company and the country's largest producer of immunobiological preparations, including vaccines, bacteriophages, and blood products. Formed in 2003 through the merger of several state-owned enterprises, it operates under the management of Nacimbio (National Immunobiological Company), a subsidiary of the Rostec State Corporation. The company's extensive portfolio covers over 250 products, including essential vaccines for the National Immunization Schedule and unique bacteriophage therapies used as alternatives to antibiotics. Microgen maintains significant manufacturing and R&D facilities across Russia, focusing on national health security and the development of innovative biological medicines.